Alexion Blood Disorder Treatment Granted Priority Review
14th Nov 2006, 18:50 GMT
The FDA has granted priority review for Alexion's drug Soliris for the treatment of a rare genetic blood disorder.
Alexion Blood Disorder Treatment Granted Priority Review related news:
- Alexion blood disorder treatment granted priority review — Pharmaceutical Business Review Latest News
- Alexion Gets Priority Review on Soliris — Bio-Technology News from StratCenter.com
- Alexion's Soliris granted priority review — United Press International - Health Business
- Alexion gets fast-track FDA review for drug Soliris — bizjournals.com Health Care:Pharmaceuticals headlines
- FDA Grants Priority Review for Soliris BLA for Treatment of Paroxysmal Nocturnal Hemoglobinuria — StratWire - Business of Healthcare NewsFeed
- Researchers Develop Novel Method For Treatment Of Sickle Cell Disease — Health News from Medical News Today
- FDA Grants Priority Review for Soliris(TM) (eculizumab) BLA for Treatment of Paroxysmal Nocturnal Hemoglobinuria — PR Newswire: All Releases
- New findings may lead to treatment for anxiety in Rett Syndrome — EurekAlert! - Chemistry, Physics and Materials Sciences
- November 13, 2006: In the News — Medscape Headlines
- NPSA issues new advice for safer blood transfusions — Computer Business Review Online Latest News
Latest news from RedOrbit News - Health:
- Pet Shop Boys Fans Know Better _ Why Bother Sharing?
- Corcept Tests Psych. Major Depression Rx
- On Its 30th Anniversary, Smokeout Provides Even More Help Quitting Smoking
- Health Plans and Disease Management Companies Are Seeking To Reduce the Use of the ER for Non-Urgent Care - Urgent Emergency Room Usage October 18, 2006 Audio Conference on CD-ROM
- Invitation Conference Call Analyst Meeting
- As Benefit Costs Rise, Employee Retirement Savings Decline
- Aetna to Help Members Quit Tobacco With New Tobacco Cessation Program
- Lilly: Arxxant Cuts Sight Loss in Diabetes
- SW Doctors PA Launch Affordable Primary Care (APC) Services
- Health Savings Technology Appoints New Management Team to Spearhead Growth in Customer-Directed Healthcare Industry